PolicyBrief
S. 4512
119th CongressMay 13th 2026
Affordable Insulin Now Act of 2026
IN COMMITTEE

This act caps insulin cost-sharing for privately insured individuals at $35 or 25% of the negotiated price (whichever is lower) starting in 2027 and establishes a federal program to reimburse providers for supplying insulin to uninsured individuals for a $35 out-of-pocket cost.

John Kennedy
R

John Kennedy

Senator

LA

LEGISLATION

New Insulin Rules Cap Monthly Costs at $35 Starting in 2027: Relief for Both Insured and Uninsured Patients

Starting January 1, 2027, the Affordable Insulin Now Act of 2026 sets a hard ceiling on what you’ll pay for life-saving insulin. For those with private insurance, the bill mandates that plans cover at least one version of every insulin type (like rapid-acting or long-acting) and limits your out-of-pocket cost to the lesser of $35 or 25% of the plan’s negotiated price for a 30-day supply. Perhaps the biggest win for your wallet is that this $35 cap applies even if you haven’t met your deductible yet, and every dollar you pay still counts toward your annual out-of-pocket maximum. It’s designed to stop the 'sticker shock' at the pharmacy counter that forces too many people to ration their doses.

The Safety Net for the Uninsured

If you don’t have health insurance, this bill doesn't leave you behind. It establishes a new Insulin Reimbursement Program where the government partners with pharmacies and clinics to bridge the gap. Under Section 3, if you’re uninsured, you can walk into a participating pharmacy and get your 30-day supply for the same $35 flat fee. The government then pays the pharmacy the difference. This is a massive shift for the gig worker or the small business owner who might be currently paying hundreds of dollars out-of-pocket just to stay healthy while managing a startup or driving for a living.

The Fine Print and Network Hurdles

While the bill is a major step forward, there are some logistical hoops to watch out for. Under Section 2, insurance plans only have to pick one 'selected' insulin product for each category to be subject to the cap. If your body responds better to a specific brand that your insurance didn't select, you might still face higher costs. Additionally, these price protections don't apply if you go to an out-of-network provider. It’s like having a coupon that only works at one grocery store; you’ll need to make sure your pharmacy and your specific brand of insulin are the ones your plan officially 'selected' to get that $35 price tag.

Who Picks Up the Tab?

There is no such thing as a free lunch, and the bill is honest about the fact that this costs money. While patients see immediate savings, health insurance companies will likely see a dip in revenue from those lost deductibles. Furthermore, Section 4 includes a 'Sense of Congress'—basically a formal nudge—stating that future laws should be passed to find the money to pay for the uninsured reimbursement program. For the average person, this means the immediate benefit is clear, but the long-term impact on insurance premiums or federal spending will depend on how the government decides to balance the books down the road.